Past Tuesday Talks — 100 Days Mission for Pandemic Preparedness

Tuesday, September 19, 2023

Presented by Seema Kumar, CEO, Cure

Cure CEO Seema Kumar moderated a conversation with Dr. Victor Dzau, President of the National Academy of Medicine, and Dr. Rick Bright, former Director of BARDA USA, about the significance of pandemic preparedness and response. They discussed the reason behind implementing the 100 Days Mission program with the International Pandemic Preparedness Secretariat.

Tuesday Talks — 100 Days Mission for Pandemic Preparedness

Topic: A fireside chat to talk pandemic preparedness and more.

Speakers: Dr. Victor Dzau, President of the National Academy of Medicine and Rick Bright, Ph.D., former Director of BARDA USA. Moderated by Seema Kumar, CEO of Cure

Featured Speakers

Dr Victor Dzau

About Victor Dzau, M.D.

Dr. Dzau is the President of the National Academy of Medicine (NAM), formerly the Institute of Medicine (IOM). In addition, he serves as Vice Chair of the National Research Council. Dr. Dzau is Chancellor Emeritus and James B. Duke Distinguished Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr. Dzau was the Hershey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital, as well as Bloomfield Professor and Chairman of the Department of Medicine at Stanford University.

Rick Bright, Ph.D.

About Rick Bright, Ph.D.

Dr. Bright is formerly the Chief Executive Officer of the Pandemic Prevention Institute (PPI) at The Rockefeller Foundation. Dr. Bright lead the development of the Foundation’s pandemic data-to-action platform that integrates modern technology, data analytics and global partners to help the world detect, prevent, and mitigate pandemic threats to achieve containment as quickly as possible.

Seema Kumar

About Seema Kumar

Seema joined Cure Experience in 2022 as the Chief Executive Officer. Prior to Cure, Ms. Kumar spent nearly 20 years at Johnson & Johnson in senior leadership roles, including most recently as the Global Head, Office of Innovation, Global Health and Scientific Engagement, and served on J&J’s Innovation Strategy, Public health leadership and the COVID-19 vaccine steering committee, where she led the company’s external affairs efforts and public education program on COVID and vaccine literacy. Before her tenure at J&J, Ms. Kumar was the Chief of Staff to Dr. Eric Lander and the Chief Communications Officer at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research where she played a leadership role in the Human Genome Project. She also has held leadership positions at the U.S. National Institutes of Allergy and Infectious Diseases (NIAID), the National Institutes of Health, and Johns Hopkins School of Medicine. Ms. Kumar holds an M.S. in Science Journalism and Communications from the University of Maryland.